Biotech In A Doldrums: Rallies Interrupted By Geopolitics, Trump Agenda And Flight To Safety

Recent geopolitical news has created a backdrop that has discouraged investors in biotech who were already risk averse from drug pricing issues. There has been little momentum over since mid-march with choppy sluggish trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.